BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy.
BMI is superior to symptoms in predicting the response to proton pump inhibitors: randomized study in patients with upper gastrointestinal symptoms and normal endoscopy.